Correction: D Quantification of Tumor Vasculature in Lymphoma Xenografts in NOD/SCID Mice Allows to Detect Differences among Vascular-Targeted Therapies

by Marco Righi, Arianna Giacomini, Loredana Cleris, Carmelo Carlo-Stella
Published 2013-01-01

(3)D [corrected] quantification of tumor vasculature in lymphoma xenografts in NOD/SCID mice allows to detect differences among vascular-targeted therapies.

by Marco Righi, Arianna Giacomini, Loredana Cleris, Carmelo Carlo-Stella
Published 2013-01-01

The Detection and Morphological Analysis of Circulating Tumor and Host Cells in Breast Cancer Xenograft Models

by Loredana Cleris, Maria Grazia Daidone, Emanuela Fina, Vera Cappelletti
Published 2019-07-01

Correction: D Quantification of Tumor Vasculature in Lymphoma Xenografts in NOD/SCID Mice Allows to Detect Differences among Vascular-Targeted Therapies.

by Marco Righi, Arianna Giacomini, Loredana Cleris, Carmelo Carlo-Stella
Published 2013-01-01

Sodium 4-Carboxymethoxyimino-(4-HPR) a Novel Water-Soluble Derivative of 4-Oxo-4-HPR Endowed with In Vivo Anticancer Activity on Solid Tumors

by Valentina Appierto, Paola Tiberio, Elena Cavadini, Loredana Cleris, Sabrina Dallavalle, Loana Musso, Maria G. Daidone
Published 2017-04-01

Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells.

by Carmelo Carlo-Stella, Silvia L Locatelli, Arianna Giacomini, Loredana Cleris, Elena Saba, Marco Righi, Anna Guidetti, Alessandro M Gianni
Published 2013-01-01